Balancing the risks and benefits of oxygen therapy in critically ill adults

Chest

Volumn 143, Issue 4, 2013, Pages 1151-1162

  Budinger, G R Scott ^a   Mutlu, Gökhan M ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR; OXYGEN; VASCULOTROPIN;

ARTERIAL OXYGEN SATURATION; ARTIFICIAL VENTILATION; BINDING AFFINITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EFFECTIVENESS; CRITICALLY ILL PATIENT; GENE EXPRESSION; HUMAN; HYPEROXIA; HYPOXEMIA; HYPOXIA; LUNG ALVEOLUS HYPOVENTILATION; LUNG INJURY; NONHUMAN; OXYGEN TENSION; OXYGEN THERAPY; OXYGENATION; PATIENT SAFETY; POSITIVE END EXPIRATORY PRESSURE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN BINDING; RESPIRATORY FAILURE; REVIEW; RISK BENEFIT ANALYSIS; TREATMENT RESPONSE;

EID: 84875977782     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.12-1215     Document Type: Article

References (124)

1. Priestley J. The Discovery of Oxygen, Part 1. Experiments by Joseph Priestly, LL.D. (1775). Chicago, IL: Albembic Club Reprints: University of Chicago Press; 1912:53-54.
2. Bean JW. Effects of oxygen at increased pressure. Physiol Rev. 1945; 25 (1) : 1 - 147.
3. Becker-Freyseng H, Clamann HG. On the question of oxygen poisoning. J Mol Med. 1939; 18 (43) : 1382 - 1385.
4. Caldwell PR, Lee WL Jr, Schildkraut HS, Archibald ER. Changes in lung volume, diffusing capacity, and blood gases in men breathing oxygen. J Appl Physiol. 1966; 21 (5) : 1477 - 1483.
5. O'Driscoll BR, Howard LS, Davison AG; British Thoracic Society. BTS guideline for emergency oxygen use in adult patients. Thorax. 2008; 63 (suppl 6) : vi1 - vi68.
6. Koopman WJH, Willems PHGM, Smeitink JAM. Monogenic mitochondrial disorders. N Engl J Med. 2012; 366 (12) : 1132 - 1141.
7. Wilson DF, Rumsey WL, Green TJ, Vanderkooi JM. The oxygen dependence of mitochondrial oxidative phosphorylation measured by a new optical method for measuring oxygen concentration. J Biol Chem. 1988; 263 (6) : 2712 - 2718.
8. Dyson A, Singer M. Tissue oxygen tension monitoring: will it fill the void? Curr Opin Crit Care. 2011; 17 (3) : 281 - 289.
9. Westlake EK, Simpson T, Kaye M. Carbon dioxide narcosis in emphysema. Q J Med. 1955; 24 (94) : 155 - 173.
10. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986; 74 (5) : 1124 - 1136.
11. Wang GL, Jiang BH, Rue EA, Semenza GL. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A. 1995; 92 (12) : 5510 - 5514.
12. Wang GL, Semenza GL. Purification and characterization of hypoxia-inducible factor 1. J Biol Chem. 1995; 270 (3) : 1230 - 1237.
13. Maxwell PH, Wiesener MS, Chang G-W, et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature. 1999; 399 (6733) : 271 - 275.
14. Hon WC, Wilson MI, Harlos K, et al. Structural basis for the recognition of hydroxyproline in HIF-1 alpha by pVHL. Nature. 2002; 417 (6892) : 975 - 978.
15. Aragonés J, Schneider M, Van Geyte K, et al. Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism. Nat Genet. 2008; 40 (2) : 170 - 180.
16. Takeda K, Ho VC, Takeda H, Duan L-J, Nagy A, Fong G-H. Placental but not heart defects are associated with elevated hypoxia-inducible factor a levels in mice lacking prolyl hydroxylase domain protein 2. Mol Cell Biol. 2006; 26 (22) : 8336 - 8346.
17. Ivan M, Kondo K, Yang H, et al. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O 2 sensing. Science. 2001; 292 (5516) : 464 - 468.
18. Epstein AC, Gleadle JM, McNeill LA, et al. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell. 2001; 107 (1) : 43 - 54.
19. Jaakkola P, Mole DR, Tian Y-M, et al. Targeting of HIF- a to the von Hippel-Lindau ubiquitylation complex by O 2 -regulated prolyl hydroxylation. Science. 2001; 292 (5516) : 468 - 472.
20. Kaelin WG Jr, Ratcliffe PJ. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol Cell. 2008; 30 (4) : 393 - 402.
21. Bruick RK, McKnight SL. A conserved family of prolyl-4- hydroxylases that modify HIF. Science. 2001; 294 (5545) : 1337 - 1340.
22. Bell EL, Emerling BM, Chandel NS. Mitochondrial regulation of oxygen sensing. Mitochondrion. 2005; 5 (5) : 322 - 332.
23. Hu C-J, Wang L-Y, Chodosh LA, Keith B, Simon MC. Differential roles of hypoxia-inducible factor 1 a (HIF-1 a) and HIF-2 a in hypoxic gene regulation. Mol Cell Biol. 2003; 23 (24) : 9361 - 9374.
24. Keith B, Johnson RS, Simon MC. HIF1 a and HIF2 a : sibling rivalry in hypoxic tumour growth and progression. Nat Rev Cancer. 2012; 12 (1) : 9 - 22.
25. Comellas AP, Dada LA, Lecuona E, et al. Hypoxia-mediated degradation of Na,K-ATPase via mitochondrial reactive oxygen ppecies and the ubiquitin-conjugating system. Circ Res. 2006;98(10):1314-1322.
26. Antonetti DA, Klein R, Gardner TW. Diabetic retinopathy. N Engl J Med. 2012; 366 (13) : 1227 - 1239.
27. Duan L-J, Takeda K, Fong G-H. Prolyl hydroxylase domain protein 2 (PHD2) mediates oxygen-induced retinopathy in neonatal mice. Am J Pathol. 2011; 178 (4) : 1881 - 1890.
28. Waypa GB, Schumacker PT. Hypoxia-induced changes in pulmonary and systemic vascular resistance: where is the O 2 sensor? Respir Physiol Neurobiol. 2010; 174 (3) : 201 - 211.
29. Sylvester JT, Shimoda LA, Aaronson PI, Ward JPT. Hypoxic pulmonary vasoconstriction. Physiol Rev. 2012; 92 (1) : 367 - 520.
30. Hopkins N, McLoughlin P. The structural basis of pulmonary hypertension in chronic lung disease: remodelling, rarefaction or angiogenesis? J Anat. 2002; 201 (4) : 335 - 348.
31. Naeije R. Pulmonary hypertension and right heart failure in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2005; 2 (1) : 20 - 22.
32. Roberts DH, Lepore JJ, Maroo A, Semigran MJ, Ginns LC. Oxygen therapy improves cardiac index and pulmonary vascular resistance in patients with pulmonary hypertension. Chest. 2001; 120 (5) : 1547 - 1555.
33. Kistler GS, Caldwell PRB, Weibel ER. Development of fine structural damage to alveolar and capillary lining cells in oxygen-poisoned rat lungs. J Cell Biol. 1967; 32 (3) : 605 - 628.
34. Laughlin MJ, Wild L, Nickerson PA, Matalon S. Effects of hyperoxia on alveolar permeability of neutropenic rabbits. J Appl Physiol. 1986; 61 (3) : 1126 - 1131.
35. Raj JU, Hazinski TA, Bland RD. Oxygen-induced lung microvascular injury in neutropenic rabbits and lambs. J Appl Physiol. 1985; 58 (3) : 921 - 927.
36. Freeman BA, Crapo JD. Hyperoxia increases oxygen radical production in rat lungs and lung mitochondria. J Biol Chem. 1981; 256 (21) : 10986 - 10992.
37. Jezek P, Hlavatá L. Mitochondria in homeostasis of reactive oxygen species in cell, tissues, and organism. Int J Biochem Cell Biol. 2005; 37 (12) : 2478 - 2503.
38. Bylund J, Brown KL, Movitz C, Dahlgren C, Karlsson A. Intracellular generation of superoxide by the phagocyte NADPH oxidase: how, where, and what for? Free Radic Biol Med. 2010; 49 (12) : 1834 - 1845.
39. Carnesecchi S, Deffert C, Pagano A, et al. NADPH oxidase-1 plays a crucial role in hyperoxia-induced acute lung injury in mice. Am J Respir Crit Care Med. 2009; 180 (10) : 972 - 981.
40. Budinger GRS, Mutlu GM, Urich D, et al. Epithelial cell death is an important contributor to oxidant-mediated acute lung injury. Am J Respir Crit Care Med. 2011; 183 (8) : 1043 - 1054.
41. Chandel NS, Budinger GR. The cellular basis for diverse responses to oxygen. Free Radic Biol Med. 2007; 42 (2) : 165 - 174.
42. Trachootham D, Lu W, Ogasawara MA, Nilsa RD, Huang P. Redox regulation of cell survival. Antioxid Redox Signal. 2008; 10 (8) : 1343 - 1374.
43. Dikalov S. Cross talk between mitochondria and NADPH oxidases. Free Radic Biol Med. 2011; 51 (7) : 1289 - 1301.
44. Cho HY, Reddy SP, Kleeberger SR. Nrf2 defends the lung from oxidative stress. Antioxid Redox Signal. 2006; 8 (1-2) : 76 - 87.
45. Li Y, Arita Y, Koo HC, Davis JM, Kazzaz JA. Inhibition of c-Jun N-terminal kinase pathway improves cell viability in response to oxidant injury. Am J Respir Cell Mol Biol. 2003; 29 (6) : 779 - 783.
46. Morse D, Otterbein LE, Watkins S, et al. Deficiency in the c-Jun NH2-terminal kinase signaling pathway confers susceptibility to hyperoxic lung injury in mice. Am J Physiol Lung Cell Mol Physiol. 2003; 285 (1) : L250 - L257.
47. O'Reilly MA. DNA damage and cell cycle checkpoints in hyperoxic lung injury: braking to facilitate repair. Am J Physiol Lung Cell Mol Physiol. 2001; 281 (2) : L291 - L305.
48. Tanaka A, Jin Y, Lee S-J, et al. Hyperoxia-induced LC3B interacts with the Fas apoptotic pathway in epithelial cell death. Am J Respir Cell Mol Biol. 2012; 46 (4) : 507 - 514.
49. Franek WR, Chowdary YC, Lin X, et al. Suppression of nuclear factor-kappa B activity by nitric oxide and hyperoxia in oxygen-resistant cells. J Biol Chem. 2002; 277 (45) : 42694 - 42700.
50. Budinger GRS, Sznajder JI. To live or die: a critical decision for the lung. J Clin Invest. 2005; 115 (4) : 828 - 830.
51. Bhandari V, Choo-Wing R, Lee CG, et al. Hyperoxia causes angiopoietin 2-mediated acute lung injury and necrotic cell death. Nat Med. 2006; 12 (11) : 1286 - 1293.
52. Siner JM, Jiang G, Cohen ZI, et al. VEGF-induced heme oxygenase-1 confers cytoprotection from lethal hyperoxia in vivo. FASEB J. 2007; 21 (7) : 1422 - 1432.
53. Budinger GR, Sznajder JI. The alveolar-epithelial barrier: a target for potential therapy. Clin Chest Med. 2006; 27 (4) : 655 - 669.
54. Asikainen TM, Schneider BK, Waleh NS, et al. Activation of hypoxia-inducible factors in hyperoxia through prolyl 4-hydroxylase blockade in cells and explants of primate lung. Proc Natl Acad Sci U S A. 2005; 102 (29) : 10212 - 10217.
55. Huang H, Van de Veire S, Dalal M, et al. Reduced retinal neovascularization, vascular permeability, and apoptosis in ischemic retinopathy in the absence of prolyl hydroxylase-1 due to the prevention of hyperoxia-induced vascular obliteration. Invest Ophthalmol Vis Sci. 2011; 52 (10) : 7565 - 7573.
56. Hall JB, Schmidt GA, Wood LDH. The Pathophysiology and Differential Diagnosis of Acute Respiratory Failure. Principles of Critical Care. 3rd ed. New York, NY : McGraw- Hill; 2005 : 417 - 426.
57. Leff AR, Schumacker PT. Respiratory Physiology: Basics and Applications. Philaldephia, PA : WB Saunders Company; 1993.
58. Pappas CT, Obara H, Bensch KG, Northway WH Jr. Effect of prolonged exposure to 80% oxygen on the lung of the newborn mouse. Lab Invest. 1983; 48 (6) : 735 - 748.
59. Frank L, Bucher JR, Roberts RJ. Oxygen toxicity in neonatal and adult animals of various species. J Appl Physiol. 1978; 45 (5) : 699 - 704.
60. Walley KR. Use of central venous oxygen saturation to guide therapy. Am J Respir Crit Care Med. 2011; 184 (5) : 514 - 520.
61. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000; 342 (18) : 1301 - 1308.
62. Wiedemann HP, Wheeler AP, Bernard GR, et al; National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med. 2006; 354 (24) : 2564 - 2575.
63. Brower RG, Lanken PN, MacIntyre N, et al; National Heart, Lung, and Blood Institute ARDS Clinical Trials Network. Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med. 2004; 351 (4) : 327 - 336.
64. Meade MO, Cook DJ, Guyatt GH, et al; Lung Open Ventilation Study Investigators. Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive endexpiratory pressure for acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA. 2008; 299 (6) : 637 - 645.
65. Mercat A, Richard JC, Vielle B, et al Expiratory Pressure (Express) Study Group. Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA. 2008; 299 (6) : 646 - 655.
66. Derdak S, Mehta S, Stewart TE, et al; Multicenter Oscillatory Ventilation For Acute Respiratory Distress Syndrome Trial (MOAT) Study Investigators. High-frequency oscillatory ventilation for acute respiratory distress syndrome in adults: a randomized, controlled trial. Am J Respir Crit Care Med. 2002; 166 (6) : 801 - 808.
67. Bollen CW, van Well GT, Sherry T, et al. High frequency oscillatory ventilation compared with conventional mechanical ventilation in adult respiratory distress syndrome: a randomized controlled trial [ISRCTN24242669]. Crit Care. 2005; 9 (4) : R430 - R439.
68. Ip T, Mehta S. The role of high-frequency oscillatory ventilation in the treatment of acute respiratory failure in adults. Curr Opin Crit Care. 2012; 18 (1) : 70 - 79.
69. Putensen C, Zech S, Wrigge H, et al. Long-term effects of spontaneous breathing during ventilatory support in patients with acute lung injury. Am J Respir Crit Care Med. 2001; 164 (1) : 43 - 49.
70. Varpula T, Valta P, Niemi R, Takkunen O, Hynynen M, Pettilä VV. Airway pressure release ventilation as a primary ventilatory mode in acute respiratory distress syndrome. Acta Anaesthesiol Scand. 2004; 48 (6) : 722 - 731.
71. Pelosi P, Bottino N, Chiumello D, et al. Sigh in supine and prone position during acute respiratory distress syndrome. Am J Respir Crit Care Med. 2003; 167 (4) : 521 - 527.
72. Briel M, Meade M, Mercat A, et al. Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis. JAMA. 2010; 303 (9) : 865 - 873.
73. Gattinoni L, Tognoni G, Pesenti A, et al; Prone-Supine Study Group. Effect of prone positioning on the survival of patients with acute respiratory failure. N Engl J Med. 2001; 345 (8) : 568 - 573.
74. Guerin C, Gaillard S, Lemasson S, et al. Effects of systematic prone positioning in hypoxemic acute respiratory failure: a randomized controlled trial. JAMA. 2004; 292 (19) : 2379 - 2387.
75. Voggenreiter G, Aufmkolk M, Stiletto RJ, et al. Prone positioning improves oxygenation in post-traumatic lung injury - a prospective randomized trial. J Trauma. 2005; 59 (2) : 333 - 341.
76. Taccone P, Pesenti A, Latini R, et al; Prone-Supine II Study Group. Prone positioning in patients with moderate and severe acute respiratory distress syndrome: a randomized controlled trial. JAMA. 2009; 302 (18) : 1977 - 1984.
77. Mancebo J, Fernández R, Blanch L, et al. A multicenter trial of prolonged prone ventilation in severe acute respiratory distress syndrome. Am J Respir Crit Care Med. 2006; 173 (11) : 1233 - 1239.
78. Fernandez R, Trenchs X, Klamburg J, et al. Prone positioning in acute respiratory distress syndrome: a multicenter randomized clinical trial. Intensive Care Med. 2008; 34 (8) : 1487 - 1491.
79. Troncy E, Collet J-P, Shapiro S, et al. Inhaled nitric oxide in acute respiratory distress syndrome: a pilot randomized controlled study. Am J Respir Crit Care Med. 1998; 157 (5 pt 1) : 1483 - 1488.
80. Michael JR, Barton RG, Saffle JR, et al. Inhaled nitric oxide versus conventional therapy: effect on oxygenation in ARDS. Am J Respir Crit Care Med. 1998; 157 (5 pt 1) : 1372 - 1380.
81. Cuthbertson BH, Galley HF, Webster NR. Effect of inhaled nitric oxide on key mediators of the inflammatory response in patients with acute lung injury. Crit Care Med. 2000; 28 (6) : 1736 - 1741.
82. Dellinger RP, Zimmerman JL, Taylor RW, et al; Inhaled Nitric Oxide in ARDS Study Group. Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Crit Care Med. 1998; 26 (1) : 15 - 23.
83. Gerlach H, Keh D, Semmerow A, et al. Dose-response characteristics during long-term inhalation of nitric oxide in patients with severe acute respiratory distress syndrome: a prospective, randomized, controlled study. Am J Respir Crit Care Med. 2003; 167 (7) : 1008 - 1015.
84. Lundin S, Mang H, Smithies M, Stenqvist O, Frostell C; The European Study Group of Inhaled Nitric Oxide. Inhalation of nitric oxide in acute lung injury: results of a European multicentre study. Intensive Care Med. 1999; 25 (9) : 911 - 919.
85. Anzueto A, Baughman RP, Guntupalli KK, et al; Exosurf Acute Respiratory Distress Syndrome Sepsis Study Group. Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. N Engl J Med. 1996; 334 (22) : 1417 - 1421.
86. Spragg RG, Lewis JF, Walmrath H-D, et al. Effect of recombinant surfactant protein C-based surfactant on the acute respiratory distress syndrome. N Engl J Med. 2004; 351 (9) : 884 - 892.
87. Kacmarek RM, Wiedemann HP, Lavin PT, Wedel MK, Tütüncü AS, Slutsky AS. Partial liquid ventilation in adult patients with acute respiratory distress syndrome. Am J Respir Crit Care Med. 2006; 173 (8) : 882 - 889.
88. Papazian L, Forel J-M, Gacouin A, et al; ACURASYS Study Investigators. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med. 2010; 363 (12) : 1107 - 1116.
89. Manthous CA, Hall JB, Olson D, et al. Effect of cooling on oxygen consumption in febrile critically ill patients. Am J Respir Crit Care Med. 1995; 151 (1) : 10 - 14.
90. Peek GJ, Mugford M, Tiruvoipati R, et al; CESAR trial collaboration. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet. 2009; 374 (9698) : 1351 - 1363.
91. Zapol WM, Snider MT, Hill JD, et al. Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. JAMA. 1979; 242 (20) : 2193 - 2196.
92. Morris AH, Wallace CJ, Menlove RL, et al. Randomized clinical trial of pressure-controlled inverse ratio ventilation and extracorporeal CO 2 removal for adult respiratory distress syndrome. Am J Respir Crit Care Med. 1994; 149 (2 pt 1) : 295 - 305.
93. Fernandes CJ Jr, Akamine N, De Marco FV, De Souza JA, Lagudis S, Knobel E. Red blood cell transfusion does not increase oxygen consumption in critically ill septic patients. Crit Care. 2001; 5 (6) : 362 - 367.
94. Parsons EC, Hough CL, Seymour CW, Cooke CR, Rubenfeld GD, Watkins TR; NHLBI ARDS Network. Red blood cell transfusion and outcomes in patients with acute lung injury, sepsis and shock. Crit Care. 2011; 15 (5) : R221.
95. Abroug F, Ouanes-Besbes L, Dachraoui F, Ouanes I, Brochard L. An updated study-level meta-analysis of randomised controlled trials on proning in ARDS and acute lung injury. Crit Care. 2011; 15 (1) : R6.
96. Yost CC, Soll RF. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database Syst Rev. 2000; (2):CD001456.
97. Eastwood G, Bellomo R, Bailey M, et al. Arterial oxygen tension and mortality in mechanically ventilated patients. Intensive Care Med. 2012; 38 (1) : 91 - 98.
98. Bellomo R, Bailey M, Eastwood GM, et al; Study of Oxygen in Critical Care (SOCC) Group. Arterial hyperoxia and in-hospital mortality after resuscitation from cardiac arrest. Crit Care. 2011; 15 (2) : R90.
99. Matute-Bello G, Frevert CW, Martin TR. Animal models of acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2008; 295 (3) : L379 - L399.
100. Fisher AB, Beers MF. Hyperoxia and acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2008; 295 (6) : L1066.
101. Northway WH Jr, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med. 1967; 276 (7) : 357 - 368.
102. Saugstad OD. Oxygen and retinopathy of prematurity. J Perinatol. 2006; 26 (suppl 1) : S46 - S50.
103. Baraldi E, Filippone M. Chronic lung disease after premature birth. N Engl J Med. 2007; 357 (19) : 1946 - 1955.
104. C arlo WA, Finer NN, Walsh MC, et al ; SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network. Target ranges of oxygen saturation in extremely preterm infants. N Engl J Med. 2010 ; 362 (21) : 1959 - 1969.
105. West JB. Respiratory Physiology: The Essentials. 8th ed. Baltimore, MD : Lippincott Williams & Wilkins; 2008.
106. Ballester E, Reyes A, Roca J, Guitart R, Wagner PD, Rodriguez-Roisin R. Ventilation-perfusion mismatching in acute severe asthma: effects of salbutamol and 100% oxygen. Thorax. 1989; 44 (4) : 258 - 267.
107. Wagner PD, Dantzker DR, Dueck R, Clausen JL, West JB. Ventilation-perfusion inequality in chronic obstructive pulmonary disease. J Clin Invest. 1977; 59 (2) : 203 - 216.
108. Agustí A G, Roca J, Gea J, Wagner P D, Xaubet A, R odriguez- Roisin R. Mechanisms of gas-exchange impairment in idiopathic pulmonary fibrosis. Am Rev Respir Dis. 1991; 143 (2) : 219 - 225.
109. Kapitän KS, Buchbinder M, Wagner PD, Moser KM. Mechanisms of hypoxemia in chronic thromboembolic pulmonary hypertension. Am Rev Respir Dis. 1989; 139 (5) : 1149 - 1154.
110. Tsang JY, Lamm WJ, Starr IR, Hlastala MP. Spatial pattern of ventilation-perfusion mismatch following acute pulmonary thromboembolism in pigs. J Appl Physiol. 2005; 98 (5) : 1862 - 1868.
111. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease : a clinical trial. Nocturnal Oxygen Therapy Trial Group. Ann Intern Med. 1980; 93 (3) : 391 - 398.
112. Aubier M, Murciano D, Fournier M, Milic-Emili J, Pariente R, Derenne JP. Central respiratory drive in acute respiratory failure of patients with chronic obstructive pulmonary disease. Am Rev Respir Dis. 1980; 122 (2) : 191 - 199.
113. Aubier M, Murciano D, Milic-Emili J, et al. Effects of the administration of O 2 on ventilation and blood gases in patients with chronic obstructive pulmonary disease during acute respiratory failure. Am Rev Respir Dis. 1980; 122 (5) : 747 - 754.
114. Dick CR, Liu Z, Sassoon CS, Berry RB, Mahutte CK. O2 -induced change in ventilation and ventilatory drive in COPD. Am J Respir Crit Care Med. 1997; 155 (2) : 609 - 614.
115. Robinson TD, Freiberg DB, Regnis JA, Young IH. The role of hypoventilation and ventilation-perfusion redistribution in oxygen-induced hypercapnia during acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000; 161 (5) : 1524 - 1529.
116. Sassoon CS, Hassell KT, Mahutte CK. Hyperoxic-induced hypercapnia in stable chronic obstructive pulmonary disease. Am Rev Respir Dis. 1987; 135 (4) : 907 - 911.
117. G ay PC, Edmonds LC. Severe hypercapnia after low-flow oxygen therapy in patients with neuromuscular disease and diaphragmatic dysfunction. Mayo Clin Proc. 1995; 70 (4) : 327 - 330.
118. Wijesinghe M, Williams M, Perrin K, Weatherall M, Beasley R. The effect of supplemental oxygen on hypercapnia in subjects with obesity-associated hypoventilation: a randomized, crossover, clinical study. Chest. 2011; 139 (5) : 1018 - 1024.
119. Perrin K, Wijesinghe M, Healy B, et al. Randomised controlled trial of high concentration versus titrated oxygen therapy in severe exacerbations of asthma. Thorax. 2011; 66 (11) : 937 - 941.
120. Gibson RL, Comer PB, Beckham RW, McGraw CP. Actual tracheal oxygen concentrations with commonly used oxygen equipment. Anesthesiology. 1976; 44 (1) : 71 - 73.
121. Parke R, McGuinness S, Eccleston M. Nasal high-flow therapy delivers low level positive airway pressure. Br J Anaesth. 2009; 103 (6) : 886 - 890.
122. Schettino G, Altobelli N, Kacmarek RM. Noninvasive positive-pressure ventilation in acute respiratory failure outside clinical trials: experience at the Massachusetts General Hospital. Crit Care Med. 2008; 36 (2) : 441 - 447.
123. H ilbert G, Gruson D, Vargas F, et al. Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure. N Engl J Med. 2001 ; 344 (7) : 481 - 487.
124. Antonelli M, Conti G, Rocco M, et al. A comparison of noninvasive positive-pressure ventilation and conventional mechanical ventilation in patients with acute respiratory failure. N Engl J Med. 1998 ; 339 (7) : 429 - 435.